Ionis Pharmaceuticals, Inc. (IONS) Total assets 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) total assets at each fiscal year-end, per SEC filings.
$3.5BFY2025 · since FY2016: $912.5M → $3.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.5B | +17.3% |
| FY2024 | $3.0B | +0.5% |
| FY2023 | $3.0B | +18.0% |
| FY2022 | $2.5B | -3.0% |
| FY2021 | $2.6B | +9.3% |
| FY2020 | $2.4B | -26.1% |
| FY2019 | $3.2B | +21.2% |
| FY2018 | $2.7B | +101.7% |
| FY2017 | $1.3B | +45.0% |
| FY2016 | $912.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IONS financial trends
IONS RevenueIONS Net incomeIONS Net marginIONS Gross profitIONS Gross marginIONS Operating incomeIONS Operating marginIONS Operating cash flowIONS Free cash flowIONS Capital expendituresIONS Return on equityIONS Stock buybacksIONS Dividends paidIONS Total liabilitiesIONS Shareholders’ equityIONS overview →